DETECTION OF PSEUDOMONAS AERUGINOSA FROM VARIOUS CLINICAL SPECIMEN AND ANTIMICROBIAL RESISTANCE PATTERN OF HUMAN
Downloads
In this study, 60 samples were collected from different sources in Al-Zahra Teaching Hospital and Karma Hospital . The random sampling process was conducted to identify the foci of pollution in P.aeruginosa, which was one of the objectives of this study and obtained diagnostic procedures. 45 samples were collected from Al-Zahra Teaching Hospital and collected from 15 samples Karma Hospital . Results of agricultural tests and tests biochemistry 10 isolates of P.aeruginosa bacteria . The pharmacological sensitivity of 10 samples was tested against 10 types of antibiotics in the method of spreading the disk to Kirby_bauer. All isolates were almost resistant . All antibiotics were resistant to severe resistance
Alhussain F, Yenugadhati N, Al Eidan F, Al Johani S and Badri M(2019) Risk factors, antimicrobial susceptibility pattern andpatient outcomes of Pseudomonas aeruginosa infection: Amatched case-control study. J. Infect. Publ. Hlth. 14(1), 152-157.
Bauer, A. W. (1966). Antibiotic susceptibility testing by a standardized single disc method. Am J clin pathol, 45, 149-158.
Holt, J. G., Krieg, N. R., Sneath, P. H., Staley, J. T., and Williams, S. T. (1994). Bergey's Manual of determinate bacteriology.
Kollef M, Shorr A, Tabak Y, Gupta V, Liu L and Johannes R (2005) Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest 128(6), 3854-3862.
Kollef M, Shorr A, Tabak Y, Gupta V, Liu L and Johannes R (2005)Epidemiology and outcomes of health-care-associatedpneumonia: results from a large US database of culture-positivepneumonia. Chest 128(6), 3854-3862.
Magnet, S. and Blanchard, J.S. (2005). Molecular insights into aminoglycoside action and resistance .Chem. Rev ., 105(2):477_498.
World Health Organization (WHO) (2017) Publisheslist of bacteriafor which new antibiotics are urgently needed. Short Summary25FebET NM WHO.pdf/. Accessed 24 January 2019
Gupta, R. S., & Shrestha, N. (2019). Clinical significance and antibiogram of Pseudomonas aeruginosa isolated from tertiary care hospital of Birgunj, Nepal. Indian J Med Res Pharm Sci, 6(8), 7-10.
Ansari, S., Dhital, R., Shrestha, S., Thapa, S., Puri, R., Chaudhary, N., ... & Gautam, R. (2016). Growing menace of antibacterial resistance in clinical isolates of Pseudomonas aeruginosa in Nepal: an insight of beta-lactamase production. BioMed Research International, 2016.
Khalifa, A. B. H., Moissenet, D., Thien, H. V., & Khedher, M. (2011, August). Virulence factors in Pseudomonas aeruginosa: mechanisms and modes of regulation. In Annales de biologie clinique (Vol. 69, No. 4, pp. 393-403).
de Bentzmann, S., Polette, M., Zahm, J. M., Hinnrasky, J., Kileztky, C., Bajolet, O., ... & Puchelle, E. (2000). Pseudomonas aeruginosa virulence factors delay airway epithelial wound repair by altering the actin cytoskeleton and inducing overactivation of epithelial matrix metalloproteinase–2. Laboratory investigation, 80(2), 209-219.
Abdullah, R. M., Dölarslan, M., & Raouf, T. F. R. (2024). Detection of (pslA, and PA-SS) Genes in Pseudomonas aeruginosa Isolated from Clinical Cases. Ibn AL-Haitham Journal For Pure and Applied Sciences, 37(2), 101-111.
Faddin JFM. Lippincott Williams & Wilkins: Biochemical Tests for Identification of Medical Bacteria; 2000..
Copyright (c) 2024 Rasha Khalid Abd Al-Baky, Hawraa Riyadh Omran , Haneen Ali Abbas , Baraa Hussein Ali, Samer Hassan Alwan, Rand Jawad Jalebawi
This work is licensed under a Creative Commons Attribution 4.0 International License.
